Japan medical startups need more than tech to break into US: VC executive

May 7

Written By Masashi Kiyomine

Masashi Kiyomine

Ruby Bio aims to launch “world first” fermentation-derived clean label emulsifiers in 2027

Kanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer Patients